$38.95
0.140.36%
At close: -
$38.11
-0.84-2.16%
After Hours: 7:59 PM EDT
Comments
Loading...
Latest CRISPR Therapeutics Stock News | NASDAQ:CRSP | Benzinga
Get the latest news on CRISPR Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CRISPR Therapeutics performance
Categories: All
Wednesday, April 09, 2025
Saturday, April 05, 2025
Wednesday, March 26, 2025
Saturday, March 15, 2025
Wednesday, March 12, 2025
Thursday, February 20, 2025
Wednesday, February 19, 2025
Tuesday, February 18, 2025
Sunday, February 16, 2025
Friday, February 14, 2025
- This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- This Informatica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
- CRISPR Therapeutics shares are trading higher...
- Morgan Stanley Maintains Underweight on CRISP...
- This Roku Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
- Evercore ISI Group Upgrades CRISPR Therapeuti...
Thursday, February 13, 2025
Wednesday, February 12, 2025
- Truist Securities Maintains Buy on CRISPR The...
- RBC Capital Maintains Sector Perform on CRISP...
- Gilead Sciences, Upstart, Mercury General, Confluent And Other Big Stocks Moving Higher On Wednesday
- CRISPR Therapeutics shares are trading higher...
- Needham Reiterates Buy on CRISPR Therapeutics...
- Barclays Maintains Equal-Weight on CRISPR The...